Xun Gui

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Cancer immunology research

Antibody therapeutics

Nature communications

mAbs

Mabwell (Shanghai) Bioscience Co., Ltd.

Hunan University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mabwell (Shanghai) Bioscience Co., Ltd. Jun 17 2019

China

Assistant of President (R&D) :: Department of Pharmacology

The University of Texas Health Science Center at Houston Dec 19 2014 - May 14 2019

United States

Postdoctoral Research Fellow :: Institute of Molecular Medicine

Education History

Hunan University Sep 01 2003 - Jun 30 2007

China

BSC :: School of Chemistry& Chemical Engineering

Publications

Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 supports immunosuppressive activity of myeloid cells and tumor development. Cancer immunology research (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Shuang Wang, Junchao Wang, Xiaojuan Yu, Wen Jiang, Shuo Chen, Rongjuan Wang, Mingzhu Wang, Shasha Jiao, Yingying Yang, Wenbo Wang, Huilin Chen, Ben Chen, Chunying Gu, Chuang Liu, An Wang, Min Wang, Gang Li, Cuicui Guo, Datao Liu, Jinchao Zhang, Min Zhang, Lan Wang, Xun Gui
Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction. Communications biology 5 (1) (2022)
Wen Jiang, Junchao Wang, Shasha Jiao, Chenjian Gu, Wei Xu, Ben Chen, Rongjuan Wang, Huilin Chen, Youhua Xie, An Wang, Gang Li, Dadi Zeng, Jinchao Zhang, Min Zhang, Shuang Wang, Mingzhu Wang, Xun Gui
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV. mAbs 13 (1) (2021)
Shuang Wang, Yun Peng, Rongjuan Wang, Shasha Jiao, Min Wang, Wei Jin Huang, Chao Shan, Wen Jiang, Zepeng Li, Chunying Gu, Ben Chen, Xue Hu, Yanfeng Yao, Juan Min, Huajun Zhang, Ying Chen, Ge Gao, Peipei Tang, Gang Li, An Wang, Lan Wang, Jinchao Zhang, Shuo Chen, Xun Gui, Zhi-Ming Yuan, Datao Liu
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys. Nature communications 11 (1) (2020)

Xun Gui.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xun Gui